Self-delivery nanoparticles of an amphiphilic irinotecan-enediyne conjugate for cancer combination chemotherapy. [electronic resource]
- Journal of materials chemistry. B 01 2019
- 103-111 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2050-7518
10.1039/c8tb02367k doi
Antineoplastic Agents--pharmacology Antineoplastic Combined Chemotherapy Protocols--pharmacology Apoptosis--drug effects Drug Delivery Systems--methods Enediynes--pharmacology HeLa Cells Humans Irinotecan--pharmacology Nanoparticles--therapeutic use